NCT00000326

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1(1)

• Status: Withdrawn
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Colorado, Denver · Academic / Other
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the clinical efficacy of the buprenorphine/naloxone combination tablet for alternate-day dosing and determine whether multiples of the daily dose are necessary to maintain an effective alternate day dosing regimen.

Detailed description

Alternate-day dosing with the 8mg buprenorphine-naloxone tablet is as safe and effective as daily dosing. Outcomes are improved when the total weekly dose provided during alternate-day dosing is equal to that given during daily dosing.

Conditions

• Heroin Dependence
• Opioid-Related Disorders

Interventions

Type	Name	Description
DRUG	Heroin Dependence

Timeline

• Start date: 1997-04-01
• Primary completion: 1997-08-01
• Completion: 1997-08-01
• First posted: 1999-09-21
• Last updated: 2017-05-04

Locations

1 site across 1 country: United States